Legal & General Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Sell |
3,695
-8,919
| -71% | -$33.1K | ﹤0.01% | 3164 |
|
|
2025
Q1 | $40.7K | Sell |
12,614
-21,666
| -63% | -$69.9K | ﹤0.01% | 2754 |
|
|
2024
Q4 | $191K | Buy |
34,280
+1,906
| +6% | +$10.6K | ﹤0.01% | 2667 |
|
|
2024
Q3 | $350K | Buy |
32,374
+2,736
| +9% | +$29.6K | ﹤0.01% | 2572 |
|
|
2024
Q2 | $622K | Buy |
29,638
+4,451
| +18% | +$93.4K | ﹤0.01% | 2346 |
|
|
2024
Q1 | $802K | Buy |
25,187
+638
| +3% | +$20.3K | ﹤0.01% | 2265 |
|
|
2023
Q4 | $497K | Buy |
24,549
+138
| +0.6% | +$2.8K | ﹤0.01% | 2450 |
|
|
2023
Q3 | $311K | Buy |
24,411
+235
| +1% | +$2.99K | ﹤0.01% | 2619 |
|
|
2023
Q2 | $437K | Buy |
24,176
+17,108
| +242% | +$309K | ﹤0.01% | 2510 |
|
|
2023
Q1 | $121K | Buy |
7,068
+4,222
| +148% | +$72.6K | ﹤0.01% | 2739 |
|
|
2022
Q4 | $63.2K | Sell |
2,846
-6,541
| -70% | -$145K | ﹤0.01% | 2907 |
|
|
2022
Q3 | $75K | Hold |
9,387
| – | – | ﹤0.01% | 2892 |
|
|
2022
Q2 | $66K | Buy |
9,387
+1,147
| +14% | +$8.07K | ﹤0.01% | 2948 |
|
|
2022
Q1 | $125K | Hold |
8,240
| – | – | ﹤0.01% | 2810 |
|
|
2021
Q4 | $181K | Buy |
8,240
+2,735
| +50% | +$60.1K | ﹤0.01% | 2763 |
|
|
2021
Q3 | $149K | Buy |
5,505
+4,691
| +576% | +$127K | ﹤0.01% | 2760 |
|
|
2021
Q2 | $20K | Buy |
814
+22
| +3% | +$541 | ﹤0.01% | 3290 |
|
|
2021
Q1 | $34K | Buy |
+792
| New | +$34K | ﹤0.01% | 2947 |
|